Age-related macular degeneration (AMD) constitutes a prevalent, chronic, and progressive
retinal degenerative disease of the macula that affects elderly people and cause central …

Neovascular age-related macular degeneration (AMD) is becoming an increasing socio-
medical problem as the proportion of the aged population is continuously increasing …

While the development of anti-vascular endothelial growth factor (anti-VEGF) as a therapy
for neovascular age-related macular degeneration (AMD) was a great success, the …

Age‐related macular degeneration (AMD) is the leading cause of blindness in the elderly
population, and the prevalence of the disease increases exponentially with every decade …

Neovascular age-related macular degeneration (exudative or wet AMD) is a prevalent,
progressive retinal degenerative macular disease that is characterized by …

Age-related macular degeneration AMD is one of the leading causes of blindness in the
elderly population. An advanced form of AMD known as neovascular AMD (nAMD) is …

Age-related macular degeneration (AMD) was described for the first time in the 1840s and is
currently the leading cause of blindness for patients over 65 years in Western Countries …

Purpose: To address the most dynamic and current issues concerning today's treatment
options and promising research efforts regarding treatment for age-related macular …

Neovascular age‐related macular degeneration is becoming an increasing socio‐medical
problem as the proportion of the aged population is continuously increasing. However, new …

Age-related macular degeneration (AMD) affects an estimated 14 million people worldwide,
and is the leading cause of severe, irreversible vision loss in individuals over the age of 50 …